Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
Clinical trial NCT03586609 · RECRUITING
Trial details
- NCT number
- NCT03586609
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-25
- Primary completion
- 2027-04-30
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.